2,2',4,4',5-Pentabromodiphenyl ether


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:15687051IVR0.06 mg/kg 0.06 mg/kgAffects sexual behaviorNeurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR0.06 mg/kg 0.06 mg/kgAffects social behaviorNeurological endocrine-mediated perturbations
IVR0.06 mg/kg 0.06 mg/kgIncreased spleen weightsImmunological endocrine-mediated perturbations
IVR0.3 mg/kg 0.3 mg/kgDecreased weights of epididymisReproductive endocrine-mediated perturbations
IVR0.3 mg/kg 0.3 mg/kgReduced sperm countsReproductive endocrine-mediated perturbations
IVR0.3 mg/kg 0.3 mg/kgAffects sexual behaviorNeurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
IVR0.3 mg/kg 0.3 mg/kgDecreased testis weightsReproductive endocrine-mediated perturbations
PMID:16451854IVR10 mg/kg 10 mg/kgDecreased weights of thyroid glandMetabolic endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgDecreased weights of pituitary gland in offspringDevelopmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations
IVR1 mg/kg 1 mg/kgDecreased weights of thyroid glandMetabolic endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgAffects anogenital distanceReproductive endocrine-mediated perturbations
IVR10 mg/kg 10 mg/kgDelayed puberty in offspringDevelopmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
PMID:17964054IVR0.06 mg/kg 0.06 mg/kgDecrease in T4 levelsMetabolic endocrine-mediated perturbations
IVR0.3 mg/kg 0.3 mg/kgAffects xenobiotic metabolismMetabolic endocrine-mediated perturbations
IVR0.3 mg/kg 0.3 mg/kgDecrease in T4 levelsMetabolic endocrine-mediated perturbations
PMID:20488217IVR0.6 mg/kg 0.6 mg/kgAffects the biochemical composition of liverHepatic endocrine-mediated perturbations
IVR0.6 mg/kg 0.6 mg/kgDecreased testosterone levelsReproductive endocrine-mediated perturbations
IVR0.6 mg/kg 0.6 mg/kgAffects intracellular signaling pathwayMetabolic endocrine-mediated perturbations
IVR0.6 mg/kg 0.6 mg/kgDecreased progesterone levelsReproductive endocrine-mediated perturbations
IVR0.6 mg/kg 0.6 mg/kgIncreased Lactate dehydrogenase (LDH) levelsMetabolic endocrine-mediated perturbations
IVR1.2 mg/kg 1.2 mg/kgAffects the biochemical composition of liverHepatic endocrine-mediated perturbations
IVR1.2 mg/kg 1.2 mg/kgAffects intracellular signaling pathwayMetabolic endocrine-mediated perturbations
IVR1.2 mg/kg 1.2 mg/kgDecreased progesterone levelsReproductive endocrine-mediated perturbations
IVR1.2 mg/kg 1.2 mg/kgIncreased Lactate dehydrogenase (LDH) levelsMetabolic endocrine-mediated perturbations
IVR1.2 mg/kg 1.2 mg/kgDecreased testosterone levelsReproductive endocrine-mediated perturbations
PMID:21783486IVR452 mg/kg 452 mg/kgAffects xenobiotic metabolismMetabolic endocrine-mediated perturbations
IVR452 mg/kg 452 mg/kgDecrease in T4 levelsMetabolic endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.